Parker Announces Retirement of Executive Chairman Thomas L. Williams and Election of Jennifer A. Parmentier as Chairman of the Board
October 25, 2023 09:14 ET
|
Parker-Hannifin Corporation
CLEVELAND, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that its Board of Directors has elected...
AGBA Group Appoints Bob Diamond as Chairman and Announces Atlas Merchant Capital as Strategic Advisor
September 19, 2023 09:15 ET
|
AGBA Group Holding Ltd
HONG KONG, Sept. 19, 2023 (GLOBE NEWSWIRE) -- NASDAQ-listed, AGBA Group Holding Limited (“AGBA”, “The Group”), the leading one-stop financial supermarket in Hong Kong, announced the appointment of...
GDS NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages GDS Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – GDS
July 21, 2023 20:31 ET
|
The Rosen Law Firm PA
NEW YORK, July 21, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GDS Holdings Limited (NASDAQ: GDS) between April 12,...
AI Therapeutics Announces Appointment of Biotechnology Industry Leader David Scheer as Chairman of the Board of Directors
July 12, 2023 11:45 ET
|
AI Therapeutics, Inc.
GUILFORD, Conn., July 12, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the appointment...
$134 Million in Financial Backing for Innovative Research and IND Fillings Announced by Ocean Biomedical (NASDAQ: OCEA); Provides Latest Updates on Advancement of Platform, Novel Discoveries in Malaria, Pulmonary Fibrosis and Oncology
April 17, 2023 08:01 ET
|
Ocean Biomedical, Inc.
Providence, RI, April 17, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (“Ocean”), a biopharma company working to accelerate the development and commercialization of scientifically compelling...
OKYO Pharma Today Announces Director Acquires Shares
March 30, 2023 02:01 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company“), an ophthalmology-focused bio-pharmaceutical company which is...
OKYO Pharma Today Announces Director Acquires Shares
March 29, 2023 02:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, March 29, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company“), an ophthalmology-focused bio-pharmaceutical company which is...
OKYO Pharma Announces PDMR Dealing
March 24, 2023 03:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, March 24, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company“), an ophthalmology-focused bio-pharmaceutical company which is...
ImCheck Appoints Thomas Civik as Independent Chairman of the Board
March 23, 2023 03:00 ET
|
ImCheck Therapeutics SAS
ImCheck Appoints Thomas Civik as Independent Chairman of the Board Marseille, France, March 23, 2023 – ImCheck Therapeutics announced today the appointment of Thomas Civik as independent...
Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
March 21, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of...